SCHEMBL27690751

SCHEMBL27690751

CCCC(=N)c1ncccc1C(=O)NC(=S)Nc1cccc(OCc2ccccc2)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 10/20 0.56
KMT2A Q03164 10/20 0.56
RAB9A P51151 3/20 0.56
ALDH1A1 P00352 10/20 0.47
MAPT P10636 3/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
LMNA P02545 3/20 0.47
NPC1 O15118 2/20 0.47
POLB P06746 2/20 0.47
ALOX12 P18054 2/20 0.46
NR1H4 Q96RI1 1/20 0.45
MAPK1 P28482 1/20 0.45
KDM4E B2RXH2 1/20 0.44
TDP1 Q9NUW8 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
HTT P42858 1/20 0.44
MGAM O43451 1/20 0.43
CTSV O60911 1/20 0.43
CTSL P07711 1/20 0.43
PDK1 Q15118 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28770444 0.90 ALDH1A1 (0.47) MEN1KMT2ARAB9AALDH1A1MAPT
SCHEMBL2862851 0.85 MEN1 (0.56) MEN1KMT2ARAB9AALDH1A1MAPT
SCHEMBL4361591 0.84 MEN1 (0.61) MEN1KMT2ARAB9AALDH1A1MAPT
SCHEMBL2866072 0.82 KMT2A (0.61) MEN1KMT2ARAB9AALDH1A1MAPT
SCHEMBL2868355 0.81 MEN1 (0.58) MEN1KMT2ARAB9AALDH1A1MAPT
SCHEMBL2868549 0.81 KMT2A (0.51) MEN1KMT2ARAB9AALDH1A1MAPT
SCHEMBL2866075 0.80 MEN1 (0.56) MEN1KMT2ARAB9AALDH1A1MAPT
SCHEMBL2869502 0.79 MEN1 (0.61) MEN1KMT2ARAB9AALDH1A1MAPT
SCHEMBL13956774 0.77 MEN1 (0.66) MEN1KMT2ARAB9AALDH1A1MAPT
SCHEMBL2866249 0.77 KMT2A (0.58) MEN1KMT2ARAB9AALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101087755-A Substituted arylacylthioureas and related compounds; inhibitors of viral replication ACHILLION PHARMACEUTICALS INC (US) 2007-12-12 CN claimed